Trial Profile
A Randomised, Double Blind Placebo Controlled, 2 Way Cross Over Study in Adults With Non-allergic Rhinitis to Evaluate the Effect of Once Daily Administration of Intranasal SB-705498 12mg for Two Weeks and the Response to a Chamber Challenge of Cold Dry Air
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jan 2024
Price :
$35
*
At a glance
- Drugs GSK 705498 (Primary)
- Indications Rhinitis
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 01 Sep 2011 New trial record